Published in N Engl J Med on August 14, 1969
Blood transfusions in elective operations: comparison of whole blood versus packed red cells. Ann Surg (1975) 0.86
Whole blood versus packed-cell transfusions: a physiologic comparison. Ann Surg (1981) 0.83
The use of packed red cells in transfusions. Calif Med (1971) 0.75
Effect of a preparative technique on the viability of concentrated red cells. Can Med Assoc J (1971) 0.75
Current transfusion therapy. Calif Med (1973) 0.75
Alloimmunization in patients with warm autoantibodies. A retrospective study employing three donor alloabsorptions to aid in antibody detection. Transfusion (1985) 1.71
Prevalence of HLA sensitization in female apheresis donors. Transfusion (1999) 1.70
Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965. Am J Med (1967) 1.34
Pregnancy and idiopathic autoimmune haemolytic anaemia: a prospective study during 6 months gestation and 3 months post-partum. Br J Haematol (1973) 1.19
Atypical antigenic properties of a gamma-A myeloma protein. J Immunol (1966) 1.11
Severe immune-mediated hemolytic anemia secondary to treatment with cefotetan. Transfusion (1992) 1.07
Combined sickle cell disease and autoimmune hemolytic anemia. Arch Intern Med (1981) 1.06
Modulation of macrophage C3b receptor function by cytochalasin-sensitive structures. J Immunol (1977) 1.05
Clinical usefulness of specific antiglobulin reagents in autoimmune hemolytic anemias. Prog Hematol (1973) 1.01
Immunologic findings in patients receiving methyldopa: a prospective study. J Lab Clin Med (1971) 0.96
Hemostatic alterations accompanying sickle cell pain crises. J Lab Clin Med (1976) 0.96
Quantitation of red blood cell-bound C3d in normal subjects and random hospitalized patients. Br J Haematol (1981) 0.92
Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises. Thromb Haemost (1980) 0.92
Current status of red-cell preservation and availability in relation to the developing national blood policy. N Engl J Med (1974) 0.91
Purification and use of the C3d subunit C3. Transfusion (1976) 0.90
Further studies of the C3g component of the alpha 2D fragment of human C3. Clin Exp Immunol (1983) 0.90
The proper use of previously frozen red blood cells for transfusion. Blood (1982) 0.89
Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises. East Afr Med J (1989) 0.89
Anti-C3d antiglobulin reagents. I. Characteristics of the anti-C3c and anti-C3d responses during hyperimmunization in rabbits. Transfusion (1974) 0.88
Comparison of low-molecular-weight products following reaction of C3-C3b with C3b inactivator and with trypsin. Vox Sang (1977) 0.86
Quantification of antibodies to the C3d subcomponent of human C3. Immunology (1977) 0.86
Grand rounds: autoimmune hemolytic anemia. Arch Intern Med (1977) 0.86
The appropriate role of frozen-stored red blood cells in transfusion practice. World J Surg (1987) 0.85
Further observations on the preparation of antiglobulin reagents reacting with c3d and c4d on red cells. Vox Sang (1977) 0.85
A simple method for preparation of C3c fragment from trypsinized serum-reacted zymosan. Transfusion (1980) 0.84
Anti-Jka, -C, and -E in a single patient, initially demonstrable only by the manual hexadimethrine bromide (Polybrene) test, with incompatibilities confirmed by 51Cr-labeled red cell studies. Transfusion (1988) 0.84
Assessment of complement binding by anti-D and anti-M antibodies employing labelled antiglobulin antibodies. Br J Haematol (1980) 0.84
Identification of a C4 Subcomponent on C3d-coated erythrocytes. Transfusion (1976) 0.83
Characterization of red blood cells strongly coated in vitro by C3 via the alternative pathway. Transfusion (1980) 0.81
Red cell-bound immunoglobulin as a predictor of severity of hemolysis in patients with autoimmune hemolytic anemia. Transfusion (1990) 0.80
Coagulation factor XIII concentration in sickle-cell disease. J Lab Clin Med (1976) 0.80
An enhancing effect of albumin on the determination of cold hemagglutinins. Vox Sang (1971) 0.80
Antinuclear antibodies in Coombs-positive acquired hemolytic anemia. Vox Sang (1968) 0.79
Anti-B-mediated rejection of an ABO-incompatible cardiac allograft despite aggressive plasma exchange transfusion. Transplant Proc (1987) 0.79
An approach to the objective measurement of spasticity. Phys Ther (1972) 0.78
Frozen storage of 11 units of sickle cell red cells for autologous transfusion of a single patient. Transfusion (1986) 0.78
The status of information about the use of blood, blood substitutes, and adjuvant solutions for extracorporeal circulation. Transfusion (1967) 0.78
A unique lymphoproliferative disorder associated with an IgM platelet agglutinin, diffuse hypergammaglobulinemia, amyloid deposition and excessive urinary excretion of IgG fragments. Am J Med (1968) 0.78
The stability of gamma-G-globulin and gamma-G related fragments in normal human urine. J Lab Clin Med (1966) 0.77
Frozen red cells revisited. N Engl J Med (1984) 0.77
Low retention of white cell fragments by polyester fiber white cell-reduction platelet filters. Transfusion (1994) 0.77
Persistent polyagglutinability in vivo unrelated to T-anigen activation. Transfusion (1970) 0.77
Life-threatening, antiglobulin test-negative, acute autoimmune hemolytic anemia due to a non-complement-activating IgG1 kappa cold antibody with Pra specificity. Transfusion (1990) 0.76
In vivo instability of red-blood-cell-bound C3d and C4d. Blood (1983) 0.76
Clinically significant allo-anti-I in an I-negative patient with massive hemorrhage. Transfusion (1986) 0.75
Blood component use in orthotopic liver transplantation. Transfusion (1988) 0.75
Gamma heavy chain disease: rapid, sustained response to cyclophosphamide and prednisone. Blood (1975) 0.75
A three-year M.D. program for students with Ph.D. degrees. J Med Educ (1986) 0.75
The role of macromolecular components in anti-gamma, alpha, mu, kappa, lambda, C3 and C4 antiglobulin sera. Br J Haematol (1971) 0.75
Inhibition of erythrocyte antibody binding by a dialysate of hemolyzed red blood cells. Clin Chim Acta (1970) 0.75
Experience of a combined apheresis, blood collection, and blood transfusion unit in a large tertiary care medical center. J Clin Apher (1991) 0.75
A latex particle assay for platelet-associated IgG. Transfusion (1992) 0.75
The difficult studies remain to be done. Transfusion (1985) 0.75
Severe paravalvular mechanical hemolysis with a normal blood smear. Am J Clin Pathol (1989) 0.75
Invalidation of antiglobulin tests by a high thermal amplitude cryoglobulin. Transfusion (1990) 0.75
Efficacy of leucocyte-poor red blood cell suspensions prepared by sedimentation in hydroxyethyl starch. Transfusion (1976) 0.75
Reproducible in vitro preparation of intermediate C3d coated red blood cells. Transfusion (1982) 0.75
Long-term in vivo survival of Rh(D)-negative donor red cells in a patient with anti-LW. Transfusion (1985) 0.75
Refractory immune hemolytic anemia with a high thermal amplitude, low affinity IgG anti-Pra cold autoantibody. Autoimmunity (1992) 0.75
Anti-C3d antiglobulin reagents. II. Preparation of an antiglobulin serum monospecific for C3d. Transfusion (1974) 0.75
Effectiveness of two synthetic fiber filters for removing white cells from AS-1 red cells. Transfusion (1989) 0.75
Hemolytic anemia complicating infectious mononucleosis due to the interaction of an IgG cold anti-i and an IgM cold rheumatoid factor. Transfusion (1982) 0.75
Fatal outcome in a patient with autoimmune hemolytic anemia associated with an IgM bithermic anti-ITP. Transfusion (1994) 0.75
Hemolytic transfusion reaction occurring in a patient with acute renal failure. Blood (1969) 0.75
Weak "false positive" direct antiglobulin test reactions with polyspecific antiglobulin reagents: lack of correlation with red-blood-cell-bound C3d. Transfusion (1982) 0.75
Release of a low molecular weight Fc-like fragment on reduction of water-insoluble IgG myeloma proteins. Vox Sang (1974) 0.75
Effect of ABO mismatching on a radioimmunoassay for platelet compatibility. Successful adsorption of ABO alloantibodies with synthetic A and B substance. Transfusion (1989) 0.75
Partial purification of an insulin inhibitor from human albumin fractions. J Clin Endocrinol Metab (1966) 0.75
Artificially induced thyroid suppression in sickle cell disease. Blood (1972) 0.75
Frozen blood. N Engl J Med (1978) 0.75
The implication of red cell-bound complement in delayed hemolytic transfusion reaction. Transfusion (1984) 0.75
Autoagglutination developing in a patient with acute renal failure. Characterization of the autoagglutinin and its relation to transfusion therapy. Br J Haematol (1968) 0.75
Positive antiglobulin reactions with thawed deglycerolized red blood cells. Vox Sang (1974) 0.75
51Chromium studies with an IgG1 anti-Yta. Immunohematology (1991) 0.75
HIV exposure in the emergency department. Mo Med (1989) 0.75
IgG, IgA, and IgM cold-reactive immunoglobulins in 19 patients with elevated cold agglutinins. J Lab Clin Med (1973) 0.75
Comparisons of pooled polyclonal rabbit anti-human C3d with four monoclonal mouse anti-human C3ds. I. Preparation, purification and binding properties. Vox Sang (1986) 0.75
Application of a modified technique to study urinary immunoglobulin light chain and whole IgG excretion in normal human subjects and patients with immune-related disorders. J Lab Clin Med (1970) 0.75
Lymphoma in primary chronic cold hemagglutinin disease treated with chlorambucil. Arch Intern Med (1982) 0.75
March hemoglobinuria associated with asymptomatic congenital heart disease. JAMA (1969) 0.75
Rosette formation by sensitized human red cells- effects of source of peripheral leukocyte monolayers. Vox Sang (1977) 0.75
Radioimmunoassay evaluation of anti-C3d reactivity in broad spectrum commercial antiglobulin reagents. Transfusion (1982) 0.75
Acute intravascular hemolytic anemia in the black rhinoceros: hematologic and immunohematologic observations. Am J Vet Res (1986) 0.75
Hematuria in hemoglobin S disorders. Arch Intern Med (1980) 0.75
Inhibition of an anti-Pr1d cold agglutinin by citrate present in commercial red cell preservative solutions. Transfusion (1990) 0.75
Multiple plasma exchanges successfully maintain a young adult patient with Crigler-Najjar syndrome type I. J Clin Apher (1989) 0.75
Combined maternal erythrocyte autosensitization and materno-fetal Jk incompatibility. Transfusion (1974) 0.75
Blood-Group Nomenclature. Science (1958) 0.75